Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Pancreatic Neoplasms 3Rectal Neoplasms 2Neoplasms 2Malnutrition 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Sarcopenia 1Prostatic Neoplasms 1Hyperphagia 1Disease 1Breast Neoplasms 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 235Leucovorin 209Irinotecan 152Radiotherapy 139Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 49Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Rectal Neoplasms × Nutrition Assessment × Gastrointestinal × Clear all
NCT05746195 2026-01-22

Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)

University of California, San Francisco

Phase NA Completed
46 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04804956 2021-10-06

BIORECTUM

University Hospital of Girona Dr. Josep Trueta

Unknown
100 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡